Please select the eligibility criteria that correspond to the clinical trial below.
Title: Emergency Department-Based Palliative Care for Advanced Cancer Patients
Brief Summary: The purpose of this study is to: 1) identify the palliative care needs of Emergency Department patients with advanced cancer, and determine if these needs can be rapidly assessed in the ED; 2) determine whether early palliative care consultation improves survival, quality of life and other burdensome symptoms and decreases utilization as compared to usual care.


Options:
A: Inclusion Criteria:

* Age ≥ 18 years and \<75 years;
* Adequate knowledge about the cancer diagnosis;
* Starting first line palliative antineoplastic treatment;
* Eastern Cooperative Oncology Group Performance Status (ECOG-PS) ≤ 2;
* Life expectancy\> 6 months and \<24 months (as per the medical oncologist);
* Must have on the following diagnoses:

Metastatic or unresectable recurrent breast cancer; Stage IIIC or IV recurrent platinum-resistant ovarian cancer; Metastatic or unresectable recurrent cervix cancer; Metastatic or unresectable recurrent endometrial cancer; Metastatic or unresectable recurrent head and neck cancer (after previous radiotherapy); Hormone-refractory metastatic or unresectable recurrent prostate cancer; Metastatic or unresectable recurrent genitourinary cancer; Metastatic or unresectable recurrent non-small cell lung cancer; Extensive-stage or recurrent small cell lung cancer; Metastatic or unresectable recurrent gastrointestinal cancer;

Exclusion Criteria:

* Currently undergoing any psychological treatment due to a psychological disorder;
* Currently using antidepressants to treat depressive disorders and / or anxiety;
* Any cognitive deficit or attention problem that could interfere in the ability to answer questionnaires or understand the study aims (as per investigator);
* Current or previous established diagnosis of any of the following psychological conditions: Substance-Related Disorders; Schizophrenia and Other Psychotic Disorders; Mood Disorders (Depressive Disorders, Bipolar Disorders); Anxiety Disorders; Dissociative Disorders; Personality Disorders; and / or a history of suicide attempt;
* Patients with single resected metastasis;
* Any co-morbid condition, which, in the opinion of the investigator, could interfere with the safety, the compliance with the study or with the interpretation of the results.
* Patients unable to go to the hospital for the study visits, regardless of the reason.
B: DISEASE CHARACTERISTICS:

* Diagnosis of 1 of the following advanced cancers:

  * Stage IIIB or IV non-small cell lung cancer
  * Extensive stage small cell lung cancer
  * Stage IV breast cancer

    * Poor prognostic indicators (conferring likelihood of ≤ 2 years survival), including, but not limited to, any of the following:

      * Visceral crisis
      * Lung or liver metastasis
      * Estrogen receptor-negative disease
      * HER2/neu-positive disease
      * Progressive or recurrent disease during or within 2 years of first treatment
  * Unresectable stage III or stage IV gastrointestinal cancers
  * Stage IV genitourinary cancers

    * Prostate cancer must be hormone refractory
* Hormone receptor status:

  * Not specified

PATIENT CHARACTERISTICS:

Sex

* Not specified

Menopausal status

* Not specified

Performance status

* Not specified

Life expectancy

* Not specified

Hematopoietic

* Not specified

Hepatic

* Not specified

Renal

* Not specified

Other

* No dementia or significant confusion (i.e., Mini Mental Exam score \< 25)
* No Axis I psychiatric disorders (DSM-IV), including any of the following:

  * Schizophrenia
  * Bipolar disorder
  * Active substance use disorder

PRIOR CONCURRENT THERAPY:

Endocrine therapy

* See Disease Characteristics
C: Inclusion Criteria:

* ≥ 18 years age
* Speak English or Spanish
* ED patient with an advanced solid malignancy

Exclusion Criteria:

* Have already been seen by palliative care team
* Cognitive deficits
* Children or adolescents
* No confirmed history of active cancer
* Do not speak English or Spanish
* Reside outside the US
D: Inclusion Criteria:

* Histologically or cytologically confirmed incurable NSCLC, stage IIIB with a pleural or pericardial effusion or stage IV
* Performance status 0-2
* Diagnosis of advanced NSCLC within the previous eight weeks
* Ability to read and respond to questions in English
* Permission of attending physician

Exclusion Criteria:

* Prior chemotherapy for metastatic disease
* Existence of other co-morbid disease, which in the opinion of the investigator prohibits participation in the protocol

Answer: C